Medicus Pharma (NASDAQ:MDCX – Get Free Report) released its earnings results on Friday. The company reported ($0.18) earnings per share for the quarter, topping the consensus estimate of ($0.32) by $0.14, Zacks reports.
Medicus Pharma Trading Down 5.2 %
Shares of NASDAQ MDCX opened at $3.13 on Friday. Medicus Pharma has a fifty-two week low of $1.80 and a fifty-two week high of $6.00. The company has a 50-day simple moving average of $3.21.
Analyst Ratings Changes
Several analysts recently weighed in on MDCX shares. Maxim Group initiated coverage on Medicus Pharma in a research note on Tuesday, December 17th. They issued a “buy” rating and a $10.00 price objective on the stock. Brookline Capital Management upgraded Medicus Pharma to a “strong-buy” rating in a report on Monday, December 23rd.
Medicus Pharma Company Profile
Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Medicus Pharma Ltd is based in Toronto, Ontario.
Read More
- Five stocks we like better than Medicus Pharma
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- MarketBeat Week in Review – 03/24 – 03/28
- What is the Dow Jones Industrial Average (DJIA)?
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Trading Stocks: RSI and Why it’s Useful
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Medicus Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicus Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
